Agency Information Collection Activities; Proposed Collection; Comment Request; Food Safety Survey, 30871-30873 [2017-13882]
Download as PDF
30871
Federal Register / Vol. 82, No. 126 / Monday, July 3, 2017 / Notices
TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1
Activity
Number of
respondents
Number of
responses per
respondent
Total annual
responses
Average
burden per
response
Total hours
Public Health Notification Readership Survey .....................
300
3
900
* 0.17
153
1 There
are no capital costs or operating and maintenance costs associated with this collection of information.
* 10 minutes.
Based on the history of the Safety
Communication program, it is estimated
that an average of three collections will
be conducted per year. The total burden
of voluntary response time is estimated
at 10 minutes per survey. This was
derived by CDRH staff completing the
survey.
Dated: June 27, 2017.
Anna K. Abram,
Deputy Commissioner for Policy, Planning,
Legislation, and Analysis.
[FR Doc. 2017–13884 Filed 6–30–17; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2017–N–0001]
Advisory Committee; Medical Imaging
Drugs Advisory Committee, Renewal
AGENCY:
Food and Drug Administration,
HHS.
Notice; renewal of advisory
committee.
ACTION:
The Food and Drug
Administration (FDA) is announcing the
renewal of the Medical Imaging Drugs
Advisory Committee by the
Commissioner of Food and Drugs (the
Commissioner). The Commissioner has
determined that it is in the public
interest to renew the Medical Imaging
Drugs Advisory Committee for an
additional 2 years beyond the charter
expiration date. The new charter will be
in effect until May 18, 2019.
DATES: Authority for the Medical
Imaging Drugs Advisory Committee will
expire on May 18, 2017, unless the
Commissioner formally determines that
renewal is in the public interest.
FOR FURTHER INFORMATION CONTACT:
Jennifer Shepherd, Center for Drug
Evaluation and Research, Food and
Drug Administration, 10903 New
Hampshire Ave., Bldg. 31, Rm. 2417,
Silver Spring, MD 20993–0002, 301–
796–9001, email: MIDAC@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Pursuant
to 41 CFR 102–3.65 and approval by the
Department of Health and Human
Services pursuant to 45 CFR part 11 and
sradovich on DSK3GMQ082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:53 Jun 30, 2017
Jkt 241001
by the General Services Administration,
FDA is announcing the renewal of the
Medical Imaging Drugs Advisory
Committee. The committee is a
discretionary Federal advisory
committee established to provide advice
to the Commissioner. The Medical
Imaging Drugs Advisory Committee
advises the Commissioner or designee
in discharging responsibilities as they
relate to helping to ensure safe and
effective drugs for human use and, as
required, any other product for which
FDA has regulatory responsibility.
The Committee reviews and evaluates
data concerning the safety and
effectiveness of marketed and
investigational human drug products for
use in diagnostic and therapeutic
procedures using radioactive
pharmaceuticals and contrast media
used in diagnostic radiology and makes
appropriate recommendations to the
Commissioner of Food and Drugs.
The Committee shall consist of a core
of 12 voting members including the
Chair. Members and the Chair are
selected by the Commissioner or
designee from among authorities
knowledgeable in the fields of nuclear
medicine, radiology, epidemiology or
statistics, and related specialties.
Members will be invited to serve for
overlapping terms of up to 4 years.
Almost all non-Federal members of this
committee serve as Special Government
Employees. The core of voting members
may include one technically qualified
member, selected by the Commissioner
or designee, who is identified with
consumer interests and is recommended
by either a consortium of consumeroriented organizations or other
interested persons. In addition to the
voting members, the Committee may
include one non-voting member who is
identified with industry interests.
Further information regarding the
most recent charter and other
information can be found at https://
www.fda.gov/AdvisoryCommittees/
CommitteesMeetingMaterials/Drugs/
MedicalImagingDrugsAdvisory
Committee/ucm273284.htm or by
contacting the Designated Federal
Officer (see FOR FURTHER INFORMATION
CONTACT). In light of the fact that no
change has been made to the committee
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
name or description of duties, no
amendment will be made to 21 CFR
14.100.
This document is issued under the
Federal Advisory Committee Act (5
U.S.C. app.). For general information
related to FDA advisory committees,
please visit us at https://www.fda.gov/
AdvisoryCommittees/default.htm.
Dated: June 27, 2017.
Anna K. Abram,
Deputy Commissioner for Policy, Planning,
Legislation, and Analysis.
[FR Doc. 2017–13885 Filed 6–30–17; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2013–N–1161]
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Food Safety
Survey
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA or Agency) is
announcing an opportunity for public
comment on the proposed collection of
certain information by the Agency.
Under the Paperwork Reduction Act of
1995 (PRA), Federal Agencies are
required to publish notice in the
Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information, and
to allow 60 days for public comment in
response to the notice. This notice
solicits comments on a voluntary
consumer survey entitled ‘‘Food Safety
Survey.’’
DATES: Submit either electronic or
written comments on the collection of
information by September 1, 2017.
ADDRESSES: You may submit comments
as follows. Please note that late,
untimely filed comments will not be
considered. Electronic comments must
be submitted on or before September 1,
2017. The https://www.regulations.gov
SUMMARY:
E:\FR\FM\03JYN1.SGM
03JYN1
30872
Federal Register / Vol. 82, No. 126 / Monday, July 3, 2017 / Notices
electronic filing system will accept
comments until midnight Eastern Time
at the end of September 1, 2017.
Comments received by mail/hand
delivery/courier (for written/paper
submissions) will be considered timely
if they are postmarked or the delivery
service acceptance receipt is on or
before that date.
sradovich on DSK3GMQ082PROD with NOTICES
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2013–N–1161 for ‘‘Agency Information
Collection Activities; Proposed
Collection; Comment Request; Food
Safety Survey.’’ Received comments,
those filed in a timely manner (see
ADDRESSES), will be placed in the docket
and, except for those submitted as
‘‘Confidential Submissions,’’ publicly
viewable at https://www.regulations.gov
or at the Dockets Management Staff
VerDate Sep<11>2014
17:53 Jun 30, 2017
Jkt 241001
between 9 a.m. and 4 p.m., Monday
through Friday.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ The
Agency will review this copy, including
the claimed confidential information, in
its consideration of comments. The
second copy, which will have the
claimed confidential information
redacted/blacked out, will be available
for public viewing and posted on
https://www.regulations.gov. Submit
both copies to the Dockets Management
Staff. If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
must identify this information as
‘‘confidential.’’ Any information marked
as ‘‘confidential’’ will not be disclosed
except in accordance with 21 CFR 10.20
and other applicable disclosure law. For
more information about FDA’s posting
of comments to public dockets, see 80
FR 56469, September 18, 2015, or access
the information at: https://www.gpo.gov/
fdsys/pkg/FR-2015-09-18/pdf/201523389.pdf.
Docket: For access to the docket to
read background documents or the
electronic and written/paper comments
received, go to https://
www.regulations.gov and insert the
docket number, found in brackets in the
heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Dockets Management
Staff, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT: Ila
S. Mizrachi, Office of Operations, Food
and Drug Administration, Three White
Flint North, 10A63, 11601 Landsdown
St., North Bethesda, MD 20852, 301–
796–7726, PRAStaff@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Under the
PRA (44 U.S.C. 3501–3520), Federal
Agencies must obtain approval from the
Office of Management and Budget
(OMB) for each collection of
information they conduct or sponsor.
‘‘Collection of information’’ is defined
in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes Agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA (44
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
U.S.C. 3506(c)(2)(A)) requires Federal
Agencies to provide a 60-day notice in
the Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information,
before submitting the collection to OMB
for approval. To comply with this
requirement, FDA is publishing notice
of the proposed collection of
information set forth in this document.
With respect to the following
collection of information, FDA invites
comments on these topics: (1) Whether
the proposed collection of information
is necessary for the proper performance
of FDA’s functions, including whether
the information will have practical
utility; (2) the accuracy of FDA’s
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and
assumptions used; (3) ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques,
when appropriate, and other forms of
information technology.
Food Safety Survey; OMB Control
Number 0910–0345—Extension
Under section 1003(b)(2) of the
Federal Food, Drug, and Cosmetic Act
(21 U.S.C. 393(b)(2)), we are authorized
to conduct research relating to foods
and to conduct educational and public
information programs relating to the
safety of the nation’s food supply. The
Food Safety Survey measures
consumers’ knowledge, attitudes, and
beliefs about food safety. Previous
versions of the survey were collected in
1988, 1993, 1998, 2001, 2006, 2010, and
2016. Food Safety Survey data are used
to measure trends in consumer food
safety habits including hand and cutting
board washing, cooking practices, and
use of food thermometers. Data are also
used to evaluate educational messages
and to inform policymakers about
consumer attitudes about technologies
such as food irradiation and
biotechnology.
The proposed Food Safety Survey will
contain many of the same questions and
topics as previous Food Safety Surveys
to facilitate measuring trends in food
safety knowledge, attitudes, and
behaviors over time. The proposed
survey will also be updated to explore
emerging consumer food safety topics
and expand understanding of previously
asked topics.
The methods for the proposed Food
Safety Survey will be largely the same
as those used with the previous Food
E:\FR\FM\03JYN1.SGM
03JYN1
30873
Federal Register / Vol. 82, No. 126 / Monday, July 3, 2017 / Notices
Safety Surveys with the exception of the
inclusion of addressed based sampling
(ABS) methods to explore the method as
a possible alternative for new survey
questions. ABS is sampling from
address frames that are usually based, in
part, on residential addresses in the U.S.
Postal Service Computerized Delivery
Sequence File. ABS is a cost effective
method of sampling that provides much
coverage of U.S. households for inperson, mail, telephone, and multimode
surveys (including Web-based surveys.)
The Food Safety Survey will continue to
include cell phones in addition to
landlines for the telephone interviews.
A nationally representative sample of
4,000 adults will be selected at random
to complete the survey. The survey will
also include an oversample of Hispanics
and Blacks to ensure a minimum of 400
each. Additionally, methods will be
employed to test for the presence of
response bias. Participation in the
survey will be voluntary. Cognitive
interviews and a pre-test will be
conducted prior to fielding the survey.
FDA estimates the burden of this
collection of information as follows:
TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1
Number of
respondents
Activity
Number of
responses per
respondent
Total
annual
responses
Average
burden per
response
Total hours
Cognitive interview screener ...............................
Cognitive interview ..............................................
Pretest screener ..................................................
Pretest .................................................................
Survey screener ..................................................
Survey .................................................................
Non-response survey screener ...........................
Non-response survey ..........................................
75
9
45
18
10,000
4,000
125
50
1
1
1
1
1
1
1
1
75
9
45
18
10,000
4,000
125
50
0.083 (5 minutes) ...........
1 .....................................
0.0167 (1 minute) ..........
0.33 (20 minutes) ...........
0.0167 (1 minute) ..........
0.33 (20 minutes) ...........
0.0167 (1 minute) ..........
0.167 (10 minutes) .........
6
9
1
6
167
1,320
2
8
Total 2 ...........................................................
........................
........................
........................
........................................
1,519
1 There
are no capital costs or operating and maintenance costs associated with this collection of information.
FDA’s burden estimate is based on the
Agency’s prior experience with the
Food Safety Survey. FDA estimates that
the burden hours for this information
collection will remain the same since
the last OMB approval.
Dated: June 27, 2017.
Anna K. Abram,
Deputy Commissioner for Policy, Planning,
Legislation, and Analysis.
[FR Doc. 2017–13882 Filed 6–30–17; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2017–N–0001]
Advisory Committees; Filing of Closed
Meeting Reports
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing
that, as required by the Federal
Advisory Committee Act, the Agency
has filed with the Library of Congress
the annual reports of those FDA
advisory committees that held closed
meetings during fiscal year 2016.
ADDRESSES: Copies are available at the
Dockets Management Staff (HFA–305),
Food and Drug Administration, 5630
Fishers Lane, Rm. 1061, Rockville, MD
20852, 240–402–7500. You also may
sradovich on DSK3GMQ082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:53 Jun 30, 2017
Jkt 241001
access the docket at https://
www.regulations.gov for the annual
reports of those FDA advisory
committees that held closed meetings
during fiscal year 2016. Insert the
docket number found in brackets in the
heading of this document at https://
www.regulations.gov into the ‘‘Search’’
box, clear filter under Document Type
(left side of screen), and check
‘‘Supporting and Related Material,’’
then Sort By Best Match (from the dropdown menu; top right side of screen),
‘‘ID Number (Z–A)’’ or Sort By Best
Match (from the drop-down menu)
‘‘Title (A–Z),’’ also found in the heading
of this document.
FOR FURTHER INFORMATION CONTACT:
Michael Ortwerth, Director and
Committee Management Officer,
Advisory Committee and Oversight
Management Staff, Food and Drug
Administration, 10903 New Hampshire
Ave., Silver Spring, MD 20993–0002,
301–796–8220.
SUPPLEMENTARY INFORMATION: Under
section 10(d) of the Federal Advisory
Committee Act (5 U.S.C. app.) and 21
CFR 14.60(d), FDA has filed with the
Library of Congress the annual reports
for the following FDA advisory
committees that held closed meetings
during the period October 1, 2015,
through September 30, 2016:
National Center for Toxicological
Research
Science Board to the National Center for
Toxicological Research
Center for Drugs Evaluation and
Research
Joint Meetings of the Anesthetic and
Analgesic Drug Products Advisory
Committee and the Drug Safety and Risk
Management Advisory Committee
Annual Reports are available for
public inspection between 9 a.m. and 4
p.m., Monday through Friday, at:
(1) The Library of Congress, Madison
Building, Newspaper and Current
Periodical Reading Room, 101
Independence Ave. SE., Rm. 133,
Washington, DC; and
(2) Dockets Management Staff (HFA–
305), Food and Drug Administration,
5630 Fishers Lane, Rm. 1061, Rockville,
MD 20852.
Dated: June 27, 2017.
Anna K. Abram,
Deputy Commissioner for Policy, Planning,
Legislation, and Analysis.
[FR Doc. 2017–13886 Filed 6–30–17; 8:45 am]
BILLING CODE 4164–01–P
Center for Biologics Evaluation and
Research
Blood Products Advisory Committee
Vaccines and Related Biological
Products Advisory Committee
PO 00000
Frm 00058
Fmt 4703
Sfmt 9990
E:\FR\FM\03JYN1.SGM
03JYN1
Agencies
[Federal Register Volume 82, Number 126 (Monday, July 3, 2017)]
[Notices]
[Pages 30871-30873]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-13882]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2013-N-1161]
Agency Information Collection Activities; Proposed Collection;
Comment Request; Food Safety Survey
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA or Agency) is announcing
an opportunity for public comment on the proposed collection of certain
information by the Agency. Under the Paperwork Reduction Act of 1995
(PRA), Federal Agencies are required to publish notice in the Federal
Register concerning each proposed collection of information, including
each proposed extension of an existing collection of information, and
to allow 60 days for public comment in response to the notice. This
notice solicits comments on a voluntary consumer survey entitled ``Food
Safety Survey.''
DATES: Submit either electronic or written comments on the collection
of information by September 1, 2017.
ADDRESSES: You may submit comments as follows. Please note that late,
untimely filed comments will not be considered. Electronic comments
must be submitted on or before September 1, 2017. The https://www.regulations.gov
[[Page 30872]]
electronic filing system will accept comments until midnight Eastern
Time at the end of September 1, 2017. Comments received by mail/hand
delivery/courier (for written/paper submissions) will be considered
timely if they are postmarked or the delivery service acceptance
receipt is on or before that date.
Electronic Submissions
Submit electronic comments in the following way:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to https://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on https://www.regulations.gov.
If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').
Written/Paper Submissions
Submit written/paper submissions as follows:
Mail/Hand delivery/Courier (for written/paper
submissions): Dockets Management Staff (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
For written/paper comments submitted to the Dockets
Management Staff, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
Instructions: All submissions received must include the Docket No.
FDA-2013-N-1161 for ``Agency Information Collection Activities;
Proposed Collection; Comment Request; Food Safety Survey.'' Received
comments, those filed in a timely manner (see ADDRESSES), will be
placed in the docket and, except for those submitted as ``Confidential
Submissions,'' publicly viewable at https://www.regulations.gov or at
the Dockets Management Staff between 9 a.m. and 4 p.m., Monday through
Friday.
Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will
review this copy, including the claimed confidential information, in
its consideration of comments. The second copy, which will have the
claimed confidential information redacted/blacked out, will be
available for public viewing and posted on https://www.regulations.gov.
Submit both copies to the Dockets Management Staff. If you do not wish
your name and contact information to be made publicly available, you
can provide this information on the cover sheet and not in the body of
your comments and you must identify this information as
``confidential.'' Any information marked as ``confidential'' will not
be disclosed except in accordance with 21 CFR 10.20 and other
applicable disclosure law. For more information about FDA's posting of
comments to public dockets, see 80 FR 56469, September 18, 2015, or
access the information at: https://www.gpo.gov/fdsys/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, Office of Operations,
Food and Drug Administration, Three White Flint North, 10A63, 11601
Landsdown St., North Bethesda, MD 20852, 301-796-7726,
PRAStaff@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501-3520), Federal
Agencies must obtain approval from the Office of Management and Budget
(OMB) for each collection of information they conduct or sponsor.
``Collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes Agency requests or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A))
requires Federal Agencies to provide a 60-day notice in the Federal
Register concerning each proposed collection of information, including
each proposed extension of an existing collection of information,
before submitting the collection to OMB for approval. To comply with
this requirement, FDA is publishing notice of the proposed collection
of information set forth in this document.
With respect to the following collection of information, FDA
invites comments on these topics: (1) Whether the proposed collection
of information is necessary for the proper performance of FDA's
functions, including whether the information will have practical
utility; (2) the accuracy of FDA's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used; (3) ways to enhance the quality,
utility, and clarity of the information to be collected; and (4) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques, when
appropriate, and other forms of information technology.
Food Safety Survey; OMB Control Number 0910-0345--Extension
Under section 1003(b)(2) of the Federal Food, Drug, and Cosmetic
Act (21 U.S.C. 393(b)(2)), we are authorized to conduct research
relating to foods and to conduct educational and public information
programs relating to the safety of the nation's food supply. The Food
Safety Survey measures consumers' knowledge, attitudes, and beliefs
about food safety. Previous versions of the survey were collected in
1988, 1993, 1998, 2001, 2006, 2010, and 2016. Food Safety Survey data
are used to measure trends in consumer food safety habits including
hand and cutting board washing, cooking practices, and use of food
thermometers. Data are also used to evaluate educational messages and
to inform policymakers about consumer attitudes about technologies such
as food irradiation and biotechnology.
The proposed Food Safety Survey will contain many of the same
questions and topics as previous Food Safety Surveys to facilitate
measuring trends in food safety knowledge, attitudes, and behaviors
over time. The proposed survey will also be updated to explore emerging
consumer food safety topics and expand understanding of previously
asked topics.
The methods for the proposed Food Safety Survey will be largely the
same as those used with the previous Food
[[Page 30873]]
Safety Surveys with the exception of the inclusion of addressed based
sampling (ABS) methods to explore the method as a possible alternative
for new survey questions. ABS is sampling from address frames that are
usually based, in part, on residential addresses in the U.S. Postal
Service Computerized Delivery Sequence File. ABS is a cost effective
method of sampling that provides much coverage of U.S. households for
in-person, mail, telephone, and multimode surveys (including Web-based
surveys.) The Food Safety Survey will continue to include cell phones
in addition to landlines for the telephone interviews. A nationally
representative sample of 4,000 adults will be selected at random to
complete the survey. The survey will also include an oversample of
Hispanics and Blacks to ensure a minimum of 400 each. Additionally,
methods will be employed to test for the presence of response bias.
Participation in the survey will be voluntary. Cognitive interviews and
a pre-test will be conducted prior to fielding the survey.
FDA estimates the burden of this collection of information as
follows:
Table 1--Estimated Annual Reporting Burden \1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of
Activity Number of responses per Total annual Average burden per response Total hours
respondents respondent responses
--------------------------------------------------------------------------------------------------------------------------------------------------------
Cognitive interview screener.............. 75 1 75 0.083 (5 minutes)........................... 6
Cognitive interview....................... 9 1 9 1........................................... 9
Pretest screener.......................... 45 1 45 0.0167 (1 minute)........................... 1
Pretest................................... 18 1 18 0.33 (20 minutes)........................... 6
Survey screener........................... 10,000 1 10,000 0.0167 (1 minute)........................... 167
Survey.................................... 4,000 1 4,000 0.33 (20 minutes)........................... 1,320
Non-response survey screener.............. 125 1 125 0.0167 (1 minute)........................... 2
Non-response survey....................... 50 1 50 0.167 (10 minutes).......................... 8
-------------------------------------------------------------------------------------------------------------
Total \2\............................. .............. .............. .............. ............................................ 1,519
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.
FDA's burden estimate is based on the Agency's prior experience
with the Food Safety Survey. FDA estimates that the burden hours for
this information collection will remain the same since the last OMB
approval.
Dated: June 27, 2017.
Anna K. Abram,
Deputy Commissioner for Policy, Planning, Legislation, and Analysis.
[FR Doc. 2017-13882 Filed 6-30-17; 8:45 am]
BILLING CODE 4164-01-P